EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antibodies in tuberculosis: functional capacity as key determinant

Krista E van Meijgaarden iD, Patricia S Grace, Natalia T Freund, Jacqueline M Achkar, Thomas Lindenstrøm, Joshua Tan, John Chan, Carolyn G King, Tom H M Ottenhoff iD, Simone A Joosten, CTVD B cell group

Infection and Immunity · 10.02.2026 · 94 (2)

DOI: 10.1128/iai.00394-25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Infection and Immunity, erschienen am 10.02.2026. Verfasst von Krista E van Meijgaarden und 10 weiteren Autor:innen. Beteiligte Einrichtung: Leiden University Center for Infectious Diseases (LUCID), Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antibodies, Bacterial, Tuberculosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human immune system employs both innate and adaptive mechanisms to control pathogens, with antibodies playing a pivotal role in immune memory and defense, in particular against viral infections. In tuberculosis, antibody titers have long been used to assess immune responses, but their presence alone fails to predict protective efficacy. Recent studies highlight that antibody functionality is critical for effective immune activity. Despite widespread detection of Mycobacterium tuberculosis (Mtb)-reactive antibodies in individuals with active disease, Mtb infection, and even in healthy controls, their potential to control Mtb growth is variable and only detected in a proportion of individuals. This perspective emphasizes the need for robust functional assessment of antibodies to better understand their role in mycobacterial control and inform vaccine development. Notably, antibodies binding to purified protein derivative of Mtb , a mixture of degraded antigens from Mtb cultures, are widespread but not universally functional, underscoring the importance of Fc characteristics and epitope specificity. Initial high-throughput screening using phagocytosis and direct mycobacterial binding assays is an active indicator of antibody function. By refining and combining existing assays, as recommended in this perspective, we can better characterize antibody contributions, particularly their immunomodulatory potential, toward improved control of Mtb . Albeit antibodies may not be essential in natural protection, functional antibodies induced by vaccination may be of added value and contribute to host protection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntibodies, BacterialTuberculosisHumansAnimals

Stichwörter der Autor:innen

antibodiesfunctional assaystuberculosis

Substanzen

Antibodies, Bacterial

Autor:innen und Institutionen

  • Leiden University Center for Infectious Diseases (LUCID), Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Clinical Microbiology and Immunology, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Department of Infectious Disease Immunology, Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
  • Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA.

ORCID-Profile: Krista E van Meijgaarden, Tom H M Ottenhoff

Zitieren

APA

van Meijgaarden, K. E., Grace, P. S., Freund, N. T., Achkar, J. M., Lindenstrøm, T., Tan, J., Chan, J., King, C. G., Ottenhoff, T. H. M., Joosten, S. A., & CTVD B cell group (2026). Antibodies in tuberculosis: functional capacity as key determinant. Infection and Immunity, 94(2). https://doi.org/10.1128/iai.00394-25

Vancouver

van Meijgaarden KE, Grace PS, Freund NT, Achkar JM, Lindenstrøm T, Tan J, et al. Antibodies in tuberculosis: functional capacity as key determinant. Infection and Immunity. 2026;94(2). doi:10.1128/iai.00394-25

BibTeX
@article{vanMeijgaarden2026,
  author = {van Meijgaarden, Krista E and Grace, Patricia S and Freund, Natalia T and Achkar, Jacqueline M and Lindenstrøm, Thomas and Tan, Joshua and Chan, John and King, Carolyn G and Ottenhoff, Tom H M and Joosten, Simone A and CTVD B cell group, CTVD B cell group},
  title = {Antibodies in tuberculosis: functional capacity as key determinant},
  journal = {Infection and Immunity},
  year = {2026},
  volume = {94},
  number = {2},
  doi = {10.1128/iai.00394-25}
}
Kostenlos starten →